Non-peptide NK1 receptors antagonists

The neurokinins are a family of mammalian neuropeptides that are involved with numerous biological activities such as pain transmission, vasodilation, smooth muscle contraction, bronchoconstriction, activation of the immune system, and neurogenic inflammation. One such neuropeptide known as substanc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Creswell, Mark Wallace, Higginbottom, Michael, Horwell, David Christopher, Lewthwaite, Russel Andrew, Pritchard, Martyn Clive, Raphy, Jennifer
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Creswell, Mark Wallace
Higginbottom, Michael
Horwell, David Christopher
Lewthwaite, Russel Andrew
Pritchard, Martyn Clive
Raphy, Jennifer
description The neurokinins are a family of mammalian neuropeptides that are involved with numerous biological activities such as pain transmission, vasodilation, smooth muscle contraction, bronchoconstriction, activation of the immune system, and neurogenic inflammation. One such neuropeptide known as substance P is widely distributed throughout the peripheral and central nervous system of mammals, and is known to mediate a variety of biological actions via interaction with three neurokinin (NK or tachykinin) receptor types known as NK , NK , and NK . Non-peptide acetamide derivatives of Formula I are specific NKantagonist, where R is aryl, Rand Rare H or alkyl, m, n and q are integers from 0 to 4, X is NRor NHCONH, Rand Rare H or alkyl, Ris naphthyl or indolyl, Rand Rare H or alkyl, and Ris aryl.The compounds are useful agents for treating inflammatory and allergic disorders, pain, anxiety, depression, schizophrenia and emesis.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06472418</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06472418</sourcerecordid><originalsourceid>FETCH-uspatents_grants_064724183</originalsourceid><addsrcrecordid>eNrjZFD1y8_TLUgtKMlMSVXw8zZUKEpNBvLyi4oVEvNKEtPz8zKLS4p5GFjTEnOKU3mhNDeDgptriLOHbmlxQWJJal5JcXx6USKIMjAzMTcyMbQwJkIJAAO1J-k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Non-peptide NK1 receptors antagonists</title><source>USPTO Issued Patents</source><creator>Creswell, Mark Wallace ; Higginbottom, Michael ; Horwell, David Christopher ; Lewthwaite, Russel Andrew ; Pritchard, Martyn Clive ; Raphy, Jennifer</creator><creatorcontrib>Creswell, Mark Wallace ; Higginbottom, Michael ; Horwell, David Christopher ; Lewthwaite, Russel Andrew ; Pritchard, Martyn Clive ; Raphy, Jennifer ; Warner-Lambert Company</creatorcontrib><description>The neurokinins are a family of mammalian neuropeptides that are involved with numerous biological activities such as pain transmission, vasodilation, smooth muscle contraction, bronchoconstriction, activation of the immune system, and neurogenic inflammation. One such neuropeptide known as substance P is widely distributed throughout the peripheral and central nervous system of mammals, and is known to mediate a variety of biological actions via interaction with three neurokinin (NK or tachykinin) receptor types known as NK , NK , and NK . Non-peptide acetamide derivatives of Formula I are specific NKantagonist, where R is aryl, Rand Rare H or alkyl, m, n and q are integers from 0 to 4, X is NRor NHCONH, Rand Rare H or alkyl, Ris naphthyl or indolyl, Rand Rare H or alkyl, and Ris aryl.The compounds are useful agents for treating inflammatory and allergic disorders, pain, anxiety, depression, schizophrenia and emesis.</description><language>eng</language><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6472418$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6472418$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Creswell, Mark Wallace</creatorcontrib><creatorcontrib>Higginbottom, Michael</creatorcontrib><creatorcontrib>Horwell, David Christopher</creatorcontrib><creatorcontrib>Lewthwaite, Russel Andrew</creatorcontrib><creatorcontrib>Pritchard, Martyn Clive</creatorcontrib><creatorcontrib>Raphy, Jennifer</creatorcontrib><creatorcontrib>Warner-Lambert Company</creatorcontrib><title>Non-peptide NK1 receptors antagonists</title><description>The neurokinins are a family of mammalian neuropeptides that are involved with numerous biological activities such as pain transmission, vasodilation, smooth muscle contraction, bronchoconstriction, activation of the immune system, and neurogenic inflammation. One such neuropeptide known as substance P is widely distributed throughout the peripheral and central nervous system of mammals, and is known to mediate a variety of biological actions via interaction with three neurokinin (NK or tachykinin) receptor types known as NK , NK , and NK . Non-peptide acetamide derivatives of Formula I are specific NKantagonist, where R is aryl, Rand Rare H or alkyl, m, n and q are integers from 0 to 4, X is NRor NHCONH, Rand Rare H or alkyl, Ris naphthyl or indolyl, Rand Rare H or alkyl, and Ris aryl.The compounds are useful agents for treating inflammatory and allergic disorders, pain, anxiety, depression, schizophrenia and emesis.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZFD1y8_TLUgtKMlMSVXw8zZUKEpNBvLyi4oVEvNKEtPz8zKLS4p5GFjTEnOKU3mhNDeDgptriLOHbmlxQWJJal5JcXx6USKIMjAzMTcyMbQwJkIJAAO1J-k</recordid><startdate>20021029</startdate><enddate>20021029</enddate><creator>Creswell, Mark Wallace</creator><creator>Higginbottom, Michael</creator><creator>Horwell, David Christopher</creator><creator>Lewthwaite, Russel Andrew</creator><creator>Pritchard, Martyn Clive</creator><creator>Raphy, Jennifer</creator><scope>EFH</scope></search><sort><creationdate>20021029</creationdate><title>Non-peptide NK1 receptors antagonists</title><author>Creswell, Mark Wallace ; Higginbottom, Michael ; Horwell, David Christopher ; Lewthwaite, Russel Andrew ; Pritchard, Martyn Clive ; Raphy, Jennifer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_064724183</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2002</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Creswell, Mark Wallace</creatorcontrib><creatorcontrib>Higginbottom, Michael</creatorcontrib><creatorcontrib>Horwell, David Christopher</creatorcontrib><creatorcontrib>Lewthwaite, Russel Andrew</creatorcontrib><creatorcontrib>Pritchard, Martyn Clive</creatorcontrib><creatorcontrib>Raphy, Jennifer</creatorcontrib><creatorcontrib>Warner-Lambert Company</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Creswell, Mark Wallace</au><au>Higginbottom, Michael</au><au>Horwell, David Christopher</au><au>Lewthwaite, Russel Andrew</au><au>Pritchard, Martyn Clive</au><au>Raphy, Jennifer</au><aucorp>Warner-Lambert Company</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Non-peptide NK1 receptors antagonists</title><date>2002-10-29</date><risdate>2002</risdate><abstract>The neurokinins are a family of mammalian neuropeptides that are involved with numerous biological activities such as pain transmission, vasodilation, smooth muscle contraction, bronchoconstriction, activation of the immune system, and neurogenic inflammation. One such neuropeptide known as substance P is widely distributed throughout the peripheral and central nervous system of mammals, and is known to mediate a variety of biological actions via interaction with three neurokinin (NK or tachykinin) receptor types known as NK , NK , and NK . Non-peptide acetamide derivatives of Formula I are specific NKantagonist, where R is aryl, Rand Rare H or alkyl, m, n and q are integers from 0 to 4, X is NRor NHCONH, Rand Rare H or alkyl, Ris naphthyl or indolyl, Rand Rare H or alkyl, and Ris aryl.The compounds are useful agents for treating inflammatory and allergic disorders, pain, anxiety, depression, schizophrenia and emesis.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_06472418
source USPTO Issued Patents
title Non-peptide NK1 receptors antagonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A27%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Creswell,%20Mark%20Wallace&rft.aucorp=Warner-Lambert%20Company&rft.date=2002-10-29&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06472418%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true